Dark

MBRX
Moleculin Biotech, Inc.
stock NASDAQ

Market Open

Nov 26, 2025 1:10:53 PM EST

0.2800USD-23.113%(-0.0830)6,827,406

0.2700Bid 0.2800Ask 0.0100Spread

Pre-market

Nov 26, 2025 9:28:30 AM EST

0.2878USD-19.855%(-0.0713)1,250,634

After-hours

Nov 25, 2025 4:51:30 PM EST

0.3591USD0.000%(0.0000)0

OverviewHistoricalExchangesShortsMore

open chart

Market Cap

14.06M

Headquarters

Houston, Texas, USA

Industry

Biotechnology

Last Split

Mar 22, 20241for15reverse

OMER XLV

MBRX Stats

Avg. Vol. 10 Day

1,882,973

Avg. Vol. 30 Day

4,120,073

Market Cap

14,056,382

Shares Out.

50,910,476

On/Off Exchange

41%/59%

6 Month Beta

1.67

1 Year Beta

1.44

2 Year Beta

1.10

3 Year Beta

0.97

52 Week Low

0.25

52 Week High

3.65

SMA50

0.47

SMA200

0.72

1 Week

-36.99%

1 Month

-44.32%

3 Month

-49.39%

6 Month

-68.98%

1 Year

-89.46%

2 Year

-96.66%

5 Year

-99.60%

Profile

moleculin biotech, inc. is a preclinical pharmaceutical company focused on the development of anti-cancer drug candidates, some of which are based on discoveries made at m.d. anderson cancer center. our lead product candidate is annamycin, a phase ii clinical stage anthracycline for the treatment of relapsed or refractory acute myeloid leukemia, more commonly referred to as aml. we also have two pre-clinical small molecule portfolios, one of which is focused on the modulation of hard-to-target tumor cell signaling mechanisms and the recruitment of the patient's own immune system. the other portfolio targets the metabolism of tumors.

MBRX Stock Summary

Moleculin Biotech, Inc. (NASDAQ:MBRX) stock price today is $0.2800, and today's volume is 6,827,406. MBRX is down -23.113% today. The 30 day average volume is 4,120,073. MBRX market cap is 14.06M with 50,910,476 shares outstanding.